Limited Recovery in business to drive earnings growth

Powered by the Sharekhan 3R Research Philosophy Consumer Discretionary Sharekhan code: TITAN Company Update Update Stock

3R MATRIX + = - Summary Right Sector (RS) ü Š We maintain our Buy recommendation on Titan with a revised PT of Rs. 1,910. It Right Quality (RQ) ü remains one of our top picks in the discretionary space due to a strong balance sheet and dominance in the branded jewellery space. Right Valuation (RV) ü Š The company expects strong recovery in pent-up demand especially in the jewellery + Positive = Neutral - Negative segment in H2FY2022; Ticket size is also expected to go up due to higher wedding spends shifted towards jewellery buying. What has changed in 3R MATRIX Š Titan has a market share of 5-6% in the jewellery market. Sustained new customer addition, strong safety standards followed by the company, omni channel platform, Old New and new product launches would help market share to improve ahead. RS  Š Balance sheet strength will help it to compete well with strong regional and large players in the domestic market. RQ  Titan Company Limited’s (Titan) market share in the jewellery market improved to 6% RV  from 4% in the last four years. Improvement in market share is largely due to strong addition of new customers every year. Around 45% of sales of the jewellery business is Reco/View Change contributed by new customers. Uncertainty in business led by frequent lockdowns had huge impact on small jewellers cash flows. This led to large shift of customers to top Reco: Buy  brands such as (by Titan) in recent times. Further, the company is focusing on strong safety standards at store level. Regular sanitisation, lesser employees per store, CMP: Rs. 1,707 and visit on appointment were some of the safety standards followed in the first wave. In Price Target: Rs. 1,910 á the second wave, the company is focusing on vaccinating all its front-end workers. Every store employee/franchisee should be vaccinated with one dose before the opening of á Upgrade  Maintain â Downgrade stores after easing of lockdown norms. Further, the company is focusing on launching light weight jewellery to fit consumer wallet in the backdrop of higher gold prices. Another Company details important factor, which will help Titan to gain market share is its omni-channel platform. Market cap: Rs. 1,51,545 cr During the first wave, Titan saw good sales on the omni-channel platform for occasional jewellery segment (with ticket size less than Rs. 50,000). This along with the company’s 52-week high/low: Rs. 1,748 / 935 focus on expanding its reach in tier 2/3 towns will help to achieve its target of having 10% market share in the jewellery space over the next two to three years. In the near NSE volume: 20.9 lakh term, management is expecting strong recovery in pent-up demand (especially for the (No of shares) wedding jewellery) due to deferment of wedding season (in the second half of FY2022). BSE code: 500114 Further, with restriction on wedding crowd in the current pandemic environment, large share of wedding spends are getting shifted to higher jewellery purchases (leading to NSE code: TITAN higher ticket size). Other businesses such as watches is expected to recover during the Free float: festive season, while eyewear business will see gradual recovery with opening of stores 41.8 cr (No of shares) and improvement in mobility. Jewellery business margins are expected to improve in the coming years due to better revenue mix and higher billing value. Better operating leverage would help watches margins to improve in the coming years. Shareholding (%) Our Call Promoters 52.9 Valuation – Maintain Buy with a revised PT of Rs. 1,910: Titan’s Jewellery business is FII 18.7 expected to post a CAGR of 15% over FY2021-FY2024. Strong growth in the jewellery business and improvement in margins would result in double-digit earnings growth over DII 11.1 the next two to three years. Strong brand recognition in the jewellery space, balance sheet Others 17.24 strength, and good return ratios make it one of the better plays in the space. The stock is currently trading at 60.8x its FY2023E earnings. We maintain our Buy recommendation Price chart on the stock with a revised PT of Rs. 1,910.

1,800 Key risk

1,550 Any disruption in the recovery of the jewellery business due to spike in COVID-19 cases followed by frequent lockdowns would act as a key risk to earnings estimates. 1,300

1,050 Valuation (consolidated) Rs cr Particulars FY20 FY21 FY22E FY23E 800 Revenue 21,052 21,644 24,770 30,307 20 21 20 21 - - - - OPM (%) 11.8 8.0 11.2 12.8 Jun Jun Oct Feb Adjusted PAT 1,519 984 1,690 2,494 Price performance Adjusted EPS (Rs.) 17.0 11.0 19.0 28.1 (%) 1m 3m 6m 12m P/E (x) 100.3 - 89.7 60.8 P/B (x) 22.7 20.2 17.5 14.2 Absolute 16.3 15.9 13.7 77.3 EV/EBIDTA (x) 61.5 88.5 54.9 39.1 Relative to RoNW (%) 23.8 13.8 20.9 25.8 10.8 10.8 2.4 21.7 Sensex RoCE (%) 30.6 17.2 26.7 34.2 Sharekhan Research, Bloomberg RoCE (%) 30.6 17.2 27.0 34.4 Source: Company; Sharekhan estimates

June 17, 2021 1 Powered by the Sharekhan

3R Research Philosophy Update Stock

Outlook and Valuation n Sector View – Recovery would take some more time; Long-term growth prospects intact Most branded apparel and retail companies were hoping of business recovering to 100% of pre-COVID levels by Q1FY2022. However, the recent spike in COVID-19 cases in would further slowdown the recovery, as few states have put restrictions on the operations of malls or have implemented localised lockdowns to curb free movement of people in the city. Retail sales were down by 49%/79% during the month of April/May 2021 (compared to pre-COVID levels) affected by localised lockdowns. Two key factors that make us believe that recovery would be faster once the rate of growing cases slows down are 1) Trend of month-on-month improvement in footfalls and higher purchases prior to the second wave of COVID-19 cases; and 2) increased pace of vaccination in India. Further, changing aspirations, higher sales through the e-commerce platform, and expansion in retail footprints in tier 3 and 4 towns would help keep the long-term structural story of the retail industry intact in India. n Company Outlook – Recovery would be faster in post easing of COVID-19 crisis Despite no sales in Q1FY2021 (affected by the first wave of COVID-19 surge), Titan registered low single-digit growth in FY2021 mainly on account of strong recovery (especially in the jewellery business) in subsequent quarters. The company was supposed to post strong recovery in FY2022 due to higher wedding demand and strong growth in tier 2 and 3 towns. However, recent developments in COVID-19 cases will put a halt to recovery. Considering strong pent-up demand in the jewellery business after the first wave of COVID-19 surge, management is confident of recovery in sales once COVID-19 situation eases down in the coming months. Higher demand for wedding jewellery due to a delayed wedding season, market share from small jewellers, and adding more stores in tier-2 and tier-3 towns would help the jewellery business to achieve double-digit growth in the medium to long term. Strong recovery in revenue of all business verticals would help profitability to improve in the coming years. n Valuation – Retain Buy with a revised PT of Rs. 1,910 Titan’s jewellery business is expected to post a CAGR of 15% over FY2021-FY2024. Strong growth in the jewellery business and margin improvement would result in double-digit earnings growth over the next two to three years. Strong brand recognition in the jewellery space, balance sheet strength, and good return ratios make it one of the better plays in the retail space. The stock is currently trading at 60.8x its FY2023E earnings. We maintain our Buy recommendation on the stock with a revised PT of Rs. 1,910.

One-year forward P/E (x) band 1,800 1,600 75x 1,400 65x 1,200 55x 1,000 45x 800 600 400 200 0 20 20 21 16 15 14 17 18 19 16 15 14 17 18 19 ------Jun - Jun - Oct Oct Oct Apr Apr Dec Nov Nov Nov Mar May May May Source: Sharekhan Research

Peer Comparison EV/EBIDTA (x) RoCE (%) Particulars FY21 FY22E FY23E FY21 FY22E FY23E 79.5 52.5 34.8 3.3 9.6 11.3 Titan Company 88.5 54.9 39.1 17.2 26.7 34.2 Source: Company, Sharekhan estimates

June 17, 2021 2 Powered by the Sharekhan

3R Research Philosophy Update Stock

About company Titan is a joint venture between and Industrial Development Corporation (TIDCO). The company is a leading organised jeweller in India with its trusted brand, Tanishq. The company started as a watch company under the brand, Titan, and is the fifth largest integrated own brand watch manufacturer in the world. The company’s key watch brands are Titan, Fastrack, and Sonata. The company is present in the eyewear segment with its brand, TitanEyeplus, and in other segments such as perfumes. The company recently entered the saree market with its brand, Taneira. Titan has a retail chain of 1,909 stores across India with a retail area crossing 2.5 million sq. ft. nationally for all its brands.

Investment theme Titan is one of India’s top retailers with a strong presence in discretionary product categories such as jewellery, watches, and eyewear. The company is one of the top brands in the watches segment; while in the jewellery space, it is gaining good acceptance because of the shift from non-branded to the branded space and expansion in middle income towns. The company endeavours to grow by 2.5x by FY2023 in its jewellery business.

Key Risks Š Increased gold prices: Any increase in gold prices would affect profitability of the jewellery segment and earnings growth of the company. Š Slowdown in discretionary consumption: Any slowdown in discretionary consumption would act as a key risk to demand of the jewellery and watches division. Š Increased competition in highly penetrated categories: Increased competition in the highly penetrated categories such as watches or jewellery would act as a threat to revenue growth.

Additional Data

Key management personnel C.K. Venkataraman Managing Director N. Muruganandam Chairman N.N. Tata Vice Chairman S. Subramaniam Chief Financial Officer Dinesh Shetty Company Secretary Source: Company Website

Top 10 shareholders Sr. No. Holder Name Holding (%) 1 Republic of India 28.2 2 Jhunjhunwala Rakesh 4.2 3 Life Insurance Corporation of India 3.6 4 BlackRock Inc. 2.15 5 Vanguard Group Inc. 1.4 6 SBI Funds Management Pvt. Ltd. 1.1 7 Jhunjhunwala Rekha Rakesh 1.09 8 Matthews International Capital Management 0.76 9 Sands Capital Management 0.68 10 ICICI Prudential Asset Management Co. Ltd. 1.11 Source: Bloomberg (old data)

Sharekhan Limited, its analyst or dependant(s) of the analyst might be holding or having a position in the companies mentioned in the article.

June 17, 2021 3 Understanding the Sharekhan 3R Matrix Right Sector Positive Strong industry fundamentals (favorable demand-supply scenario, consistent industry growth), increasing investments, higher entry barrier, and favorable government policies Neutral Stagnancy in the industry growth due to macro factors and lower incremental investments by Government/private companies Negative Unable to recover from low in the stable economic environment, adverse government policies affecting the business fundamentals and global challenges (currency headwinds and unfavorable policies implemented by global industrial institutions) and any significant increase in commodity prices affecting profitability. Right Quality Positive Sector leader, Strong management bandwidth, Strong financial track-record, Healthy Balance sheet/cash flows, differentiated product/service portfolio and Good corporate governance. Neutral Macro slowdown affecting near term growth profile, Untoward events such as natural calamities resulting in near term uncertainty, Company specific events such as factory shutdown, lack of positive triggers/events in near term, raw material price movement turning unfavourable Negative Weakening growth trend led by led by external/internal factors, reshuffling of key management personal, questionable corporate governance, high commodity prices/weak realisation environment resulting in margin pressure and detoriating balance sheet Right Valuation Positive Strong earnings growth expectation and improving return ratios but valuations are trading at discount to industry leaders/historical average multiples, Expansion in valuation multiple due to expected outperformance amongst its peers and Industry up-cycle with conducive business environment. Neutral Trading at par to historical valuations and having limited scope of expansion in valuation multiples. Negative Trading at premium valuations but earnings outlook are weak; Emergence of roadblocks such as corporate governance issue, adverse government policies and bleak global macro environment etc warranting for lower than historical valuation multiple. Source: Sharekhan Research Know more about our products and services

For Private Circulation only

Disclaimer: This document has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity to which it is addressed to. This Document may contain confidential and/or privileged material and is not for any type of circulation and any review, retransmission, or any other use is strictly prohibited. This Document is subject to changes without prior notice. This document does not constitute an offer to sell or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report. The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN has not independently verified the accuracy and completeness of the said data and hence it should not be relied upon as such. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Recipients of this report should also be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusions from the information presented in this report. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. The analyst certifies that the analyst has not dealt or traded directly or indirectly in securities of the company and that all of the views expressed in this document accurately reflect his or her personal views about the subject company or companies and its or their securities and do not necessarily reflect those of SHAREKHAN. The analyst further certifies that neither he or its associates or his relatives has any direct or indirect financial interest nor have actual or beneficial ownership of 1% or more in the securities of the company at the end of the month immediately preceding the date of publication of the research report nor have any material conflict of interest nor has served as officer, director or employee or engaged in market making activity of the company. Further, the analyst has also not been a part of the team which has managed or co-managed the public offerings of the company and no part of the analyst’s compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this document. Sharekhan Limited or its associates or analysts have not received any compensation for investment banking, merchant banking, brokerage services or any compensation or other benefits from the subject company or from third party in the past twelve months in connection with the research report. Either SHAREKHAN or its affiliates or its directors or employees / representatives / clients or their relatives may have position(s), make market, act as principal or engage in transactions of purchase or sell of securities, from time to time or may be materially interested in any of the securities or related securities referred to in this report and they may have used the information set forth herein before publication. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind.

Compliance Officer: Mr. Joby John Meledan; Tel: 022-61150000; email id: [email protected]; For any queries or grievances kindly email [email protected] or contact: [email protected]

Registered Office: Sharekhan Limited, 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), – 400042, . Tel: 022 - 61150000. Sharekhan Ltd.: SEBI Regn. Nos.: BSE / NSE / MSEI (CASH / F&O / CD) / MCX - Commodity: INZ000171337; DP: NSDL/CDSL-IN-DP-365-2018; PMS: INP000005786; Mutual Fund: ARN 20669; Research Analyst: INH000006183;

Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and the T&C on www.sharekhan.com; Investment in securities market are subject to market risks, read all the related documents carefully before investing.